TABLE 3.
Overall clinical response to IL-2 treatment in evaluable patients
Response | Brain metastases previously treated n = 27 (%) | Brain metastases untreated n = 36 (%) | No brain metastases n = 1003 (%) |
---|---|---|---|
CR | 0 | 1 (2.8) | 58 (5.8) |
PR | 5 (18.5) | 1 (2.8) | 141 (14.1) |
Total | 5 (18.5)* | 2 (5.6)† | 199 (19.8) |
7/63 (11.1) |
p = NS versus no brain metastases.
p = 0.031 by Fisher’s exact test (trend toward significance) versus no brain metastases.